AKTIS Oncology initiated as Outperform by Oppenheimer
AKTIS Oncology was initiated with an Outperform rating by Oppenheimer.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.